NCT00103311View on ClinicalTrials.gov

SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

January 31, 2010

Study Completion Date

September 30, 2010

Conditions
Recurrent Colon CancerRecurrent Rectal CancerStage IIIA Colon CancerStage IIIA Rectal CancerStage IIIB Colon CancerStage IIIB Rectal CancerStage IIIC Colon CancerStage IIIC Rectal CancerStage IVA Colon CancerStage IVA Rectal CancerStage IVB Colon CancerStage IVB Rectal Cancer
Interventions
DRUG

ispinesib

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

90033

University of Southern California, Norris, Los Angeles

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00103311 - SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter